A year marked by significative strategic investments and by the first sale of the Ikoniscope20 solution, including newly added reagents in partnership with Empire Genomics, to the first US customer
Ikonisys publishes its Full-Year Financial Results for 2022 and provides an update on its latest developments streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Acceleration of the commercialization and R&D strategy to lay the groundwork for sales growth: Appointment of Gabriel Plan as Sales Director in France; Successful installation of
Successful IPO in July 2021 on Euronext Growth Paris Successful installation of the Ikoniscope20 at Tomalab, one of the largest genetic laboratories in Italy (post-closing) The Ikoniscope20
Ikonisys SA Announces the Appointment of Gabriel Plan as France Sales Director morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.